Prior COVID-19 vaccination did not stop the immune system from mounting a protective response to the delta and omicron strains, though new mutation-specific antibody production dipped slightly, according to a study led by ...
May 27, 2025
1
117
mRNA vaccines, like COVID-19 vaccines, work better if patients are in a good mood, finds new research by Cardiff University.
Apr 2, 2025
0
24
In the early days of the COVID-19 pandemic, researchers struggled to grasp the rate of the virus's spread and the number of related deaths. While hospitals tracked cases and deaths within their walls, the broader picture ...
Mar 20, 2025
0
13
An experimental vaccine has shown promise in protecting against the sexually transmitted disease chlamydia, researchers report.
Nov 15, 2024
0
34
New research helps explain why young children have lower rates of severe COVID-19 than adults. A study of infants and young children found those who acquired SARS-CoV-2 had a strong, sustained antibody response to the virus ...
Oct 15, 2023
0
58
Researchers and clinicians from the University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust are part of the ongoing OCTAVE (Observational Cohort Trial-T-cells Antibodies and Vaccine Efficacy in SARS-CoV-2) ...
Jul 7, 2023
0
120
A new nasal pertussis vaccine against whooping cough has shown promising results. The vaccine was shown to be safe and to work against whooping cough in a study conducted in healthy adults. Professor Qiushui He and Project ...
Apr 24, 2023
0
57
The Yoko Hamazaki Laboratory at CiRA has reported that the slower onset of helper T-cell responses in the elderly after COVID-19 vaccinations is associated with lower antibody production, killer T cell activation, and frequency ...
Jan 13, 2023
0
68
New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, demonstrated that withholding mycophenolate mofetil for at least 10 days significantly increased antibody response ...
Nov 8, 2022
0
37
COVID-19 vaccines boast efficacy rates against severe disease and hospitalization as high as 95%. But even among young, healthy adults, this doesn't mean individuals who received the groundbreaking jab acquired equal protection. ...
Nov 2, 2022
1
84
